Univadis

What Univadis does

Univadis is the international/regional brand of the Medscape medical information platform, owned by WebMD LLC and headquartered in Reading, UK, with parent operations in New York. It provides physicians, pharmacists, nurses, residents, and medical students with daily medical news, clinical trial updates, treatment guidelines, drug reference, and continuing medical education across more than 30 specialties. Distribution is delivered through a web platform, native iOS and Android mobile applications, email newsletters, virtual events, and six language editions (English, German, Spanish, French, Portuguese, UK English), giving it multi-channel, multi-market reach into the global healthcare professional population.

The product surface combines clinical reference tools (Formulary Plan Manager, Medscape Surveys, Salary Explorer), personalized content delivery ('For You' newsfeed, saved watchlists), and CME/CE activities for licensure maintenance. Recent additions include Medscape AI Search and Medscape Scribe, positioning the platform to capture workflow-adjacent AI use cases for HCPs. Strategic conference partnerships (BAD 2026, ESHRE 2026, HLTH Europe 2026) reinforce specialty authority and content credibility.

The business model is advertising- and sponsorship-driven: pharmaceutical companies, medical device manufacturers, and healthcare organizations pay to promote products and sponsor CME/CE programs to the registered HCP user base. Core medical news and reference content is provided free to healthcare professionals, so monetization is on the demand-side (advertisers/sponsors) rather than the supply-side (HCP users). Pricing to HCPs is not publicly disclosed, and there are no disclosed funding rounds, headcount figures, or standalone revenue for Univadis.

Name

Univadis

Legal name

WebMD LLC

Website

https://univadis.com

Company type

Private

Founded year

1994

Operating status

Operating

Short description

Univadis is the international brand of Medscape, owned by WebMD LLC, providing physicians, pharmacists, nurses, and medical students with clinical news, reference tools, CME/CE, and AI features across six language editions globally.

Ownership category

akta.pro rank

Product category

Medical Information Platform

NAICS

Web Search Portals, Libraries, Archives, and Other Information Services (5192)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industry

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)

Keywords

• Medical news platform
• Clinical reference tools
• Continuing medical education
• Healthcare professional resources
• Medical specialty content

Headquarters

HQ city

Reading

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Pharmaceutical and Healthcare Advertising: Advertising revenue from pharmaceutical companies, medical device manufacturers, and healthcare organizations promoting their products to medical professionals
2. CME/CE Sponsorships: Continuing medical education programs sponsored by pharmaceutical and medical device companies seeking to educate physicians on their products

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Univadis is an online medical information platform, operating as a regional brand of Medscape, that provides healthcare professionals with daily medical news, clinical trial coverage, treatment guidelines, drug reference tools, and continuing medical education (CME/CE) programs across 30+ medical specialties. The platform is available free of charge to physicians, nurses, pharmacists, residents, and medical students via web and mobile applications in multiple languages including English, German, Spanish, French, and Portuguese.

Product overview

Univadis is a medical information platform operated by Medscape that provides healthcare professionals with access to clinical news, medical education, reference tools, and professional resources. The core offering includes a mobile application alongside web-based content covering multiple medical specialties including Cardiology, Diabetes & Endocrinology, Family Medicine, Hematology-Oncology, Neurology, Psychiatry, and many others. Medscape also provides tools such as Salary Explorer, Surveys, and Scribe (AI scribe functionality), along with CME/CE education, video content, and conference coverage.

Differentiator

Problem solved

Functional benefit

Brands

• Medscape: Primary medical news, clinical reference, and professional education platform providing medical content across multiple specialties.
• Univadis from Medscape

Products and services

• Medscape Mobile App A mobile application available on iOS (App Store) and Android (Google Play) that allows healthcare professionals to access medical news, clinical references, drug information, continuing medical education activities, and specialty-specific content on the go.
• Medscape Web Platform The main Medscape/Univadis web platform providing daily medical news, clinical trial updates, treatment guidelines, drug reference tools, specialty-specific content across 30+ medical specialties, and access to professional resources.
• CME/CE Education Programs Continuing medical education activities delivered through articles, videos, and virtual events that allow healthcare professionals to earn CME/CE credits for licensure maintenance while consuming clinical content. These programs are sponsored by pharmaceutical and medical device companies.

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• European Society of Human Reproduction and Embryology (ESHRE)coreStrategic or Co-development Partner · 5 July 2026Medscape/Univadis provides coverage of the ESHRE 2026 conference scheduled July 5-8, 2026 at London, UK, sharing clinical research and scientific advances with the medical community.
• British Association of Dermatologists (BAD)coreStrategic or Co-development Partner · 30 June 2026Medscape/Univadis provides coverage of the BAD 2026 Annual Meeting held June 30-July 2, 2026 at Manchester Central, UK. Coverage includes medical news articles and clinical updates from the conference proceedings.
• HLTH EuropeminorStrategic or Co-development Partner · 15 June 2026Medscape/Univadis provides coverage of HLTH Europe 2026 healthcare innovation conference held June 15-18, 2026 in Amsterdam, The Netherlands.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Doximity: US-based physician professional network offering news, clinical reference, and CME, directly competing with Medscape/Univadis for daily HCP engagement and pharma marketing dollars.
• Sermo: Global physician community and medical-information platform serving doctors with surveys, clinical content, and pharma-sponsored insights — highly comparable to Univadis's HCP audience and advertising-driven model.
• epocrates: Clinical drug reference and point-of-care decision tool owned by Wolters Kluwer, used by physicians for formulary and prescribing lookup — overlaps directly with Univadis's Formulary Plan Manager and drug reference features.
• Healio: Specialty-focused medical news, CME, and education platform serving physicians across multiple specialties — closely comparable to Univadis's specialty news and CME/CE value proposition.
• Pri-Med: Provider of CME/CE programs and clinical education for primary care physicians, overlapping with Univadis's CME/CE sponsorship and clinician education business.

Broad incumbents

• UpToDate: Wolters Kluwer's flagship evidence-based clinical decision support resource used by physicians worldwide; competes for the same clinician reference time budget as Univadis's Tools & Reference offering.
• BMJ (British Medical Journal): Major medical publisher and CME provider with global physician reach, particularly strong in the UK and Commonwealth — competing with Univadis for editorial credibility and accredited medical education audiences.
• Medscape (US brand): Main US edition of the Medscape brand under the same WebMD LLC parent; functionally the primary US counterpart to Univadis and the most directly comparable product in terms of audience, content mix, and sponsor monetization.
• Elsevier ClinicalKey: Elsevier's clinical reference and decision-support platform used by physicians and institutions; competes with Univadis's Tools & Reference functionality for the same evidence-based clinical information use case.

Emerging players

• Figure 1 (now part of HIMSS): Physician-focused medical knowledge-sharing platform with case-based content and HCP community features — partial overlap with Univadis's news and reference use cases, particularly in continuing education.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/univadis
• Facebookfacebook.com/Univadis
• LinkedInlinkedin.com/company/univadis

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Univadis